Literature DB >> 31462547

A Cost-Effective Method for Identifying Enterobacterales with OXA-181.

Gisele Peirano1,2, Yasufumi Matsumura3, Diego Nobrega4, Johann D D Pitout5,2,6,7.   

Abstract

OXA-181 is the second most common global OXA-48-like carbapenemase and is endemic in the Indian subcontinent. Molecular studies have shown that Enterobacterales with OXA-181 are often introduced into regions of nonendemicity. Distinguishing OXA-181 from other OXA-48-like enzymes often requires sequencing, which is rather expensive and time-consuming. A specific PCR (i.e., OXA181PCR) for the detection of bla OXA-181 was validated using a global collection (n = 315) of bacteria with well-characterized carbapenemases and showed 100% sensitivity and specificity (95% confidence interval [CI], 94.1 to 100 and 98.6 to 100, respectively) for detecting bacteria with OXA-181. The OXA181PCR subsequently gave positive results on 58/160 (36%) Enterobacterales with OXA-48-like carbapenemases from the 2015 INFORM surveillance program. The bla OXA-181-positive Enterobacterales were present in 9 countries spanning 5 continents, illustrating the global distribution of OXA-181. This methodology can easily be incorporated into molecular surveillance programs to provide accurate information about the prevalence of OXA-181. A loop-mediated isothermal amplification (LAMP)-OXA48 assay overall performed well for detecting OXA-48-like enzymes but showed poor specificity due to false-positive results with non-OXA carbapenemases.
Copyright © 2019 American Society for Microbiology.

Keywords:  OXA-181; carbapenemases; detection

Year:  2019        PMID: 31462547      PMCID: PMC6813009          DOI: 10.1128/JCM.01281-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.

Authors:  Laurent Poirel; Alain Ros; Anne Carricajo; Philippe Berthelot; Bruno Pozzetto; Sandrine Bernabeu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

2.  Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Dilip Mathai; Jan M Bell; Ronald N Jones; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

3.  Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.

Authors:  Deborah A Williamson; Helen Heffernan; Hanna Sidjabat; Sally A Roberts; David L Paterson; Marian Smith; Joshua T Freeman
Journal:  J Antimicrob Chemother       Date:  2011-09-19       Impact factor: 5.790

4.  Rapid and simple identification of carbapenemase genes, bla NDM, bla OXA-48, bla VIM, bla IMP-14 and bla KPC groups, in Gram-negative bacilli by in-house loop-mediated isothermal amplification with hydroxynaphthol blue dye.

Authors:  Arpasiri Srisrattakarn; Aroonlug Lulitanond; Chotechana Wilailuckana; Nicha Charoensri; Lumyai Wonglakorn; Pimjai Saenjamla; Prajuab Chaimanee; Jureerut Daduang; Aroonwadee Chanawong
Journal:  World J Microbiol Biotechnol       Date:  2017-06-05       Impact factor: 3.312

Review 5.  Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae.

Authors:  Yasufumi Matsumura; Johann D Pitout
Journal:  Expert Rev Mol Diagn       Date:  2016-04-18       Impact factor: 5.225

6.  Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae.

Authors:  Anaïs Potron; Patrice Nordmann; Emilie Lafeuille; Zaina Al Maskari; Fatma Al Rashdi; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

7.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Klebsiella pneumoniae ST307 with blaOXA-181, South Africa, 2014-2016.

Authors:  Michelle Lowe; Marleen M Kock; Jennifer Coetzee; Ebrahim Hoosien; Gisele Peirano; Kathy-Ann Strydom; Marthie M Ehlers; Nontombi M Mbelle; Elena Shashkina; David B Haslam; Puneet Dhawan; Robert J Donnelly; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

9.  OXA-181-producing Klebsiella pneumoniae establishing in Singapore.

Authors:  Michelle N D Balm; Grace Ngan; Roland Jureen; Raymond T P Lin; Jeanette W P Teo
Journal:  BMC Infect Dis       Date:  2013-02-01       Impact factor: 3.090

10.  Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008-2014.

Authors:  Gisele Peirano; Yasufumi Matsumura; Mark D Adams; Patricia Bradford; Mary Motyl; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

View more
  2 in total

Review 1.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

2.  Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting.

Authors:  K A Strydom; L Chen; M M Kock; A C Stoltz; G Peirano; D B Nobrega; M Lowe; M M Ehlers; N M Mbelle; B N Kreiswirth; J D D Pitout
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.